1963-21-9 Usage
Description
Glycyl-L-valine, also known as Gly-Val, is a dipeptide formed from glycine and L-valine residues. It is a white, fine crystalline powder with unique chemical properties that make it suitable for various applications across different industries.
Uses
Used in Pharmaceutical Industry:
Glycyl-L-valine is used as an active pharmaceutical ingredient for its potential therapeutic effects. The dipeptide structure allows it to interact with specific biological targets, making it a valuable compound in the development of new drugs.
Used in Nutritional Supplements:
Glycyl-L-valine is used as a key component in nutritional supplements, particularly those aimed at enhancing muscle growth and recovery. Its dipeptide structure facilitates better absorption and utilization by the body, contributing to improved athletic performance and muscle maintenance.
Used in Cosmetics Industry:
In the cosmetics industry, Glycyl-L-valine is used as an ingredient in skincare and hair care products due to its moisturizing and conditioning properties. Its ability to penetrate the skin and hair shafts helps improve the overall texture and appearance of the skin and hair.
Used in Food Industry:
Glycyl-L-valine is used as a flavor enhancer and a component in the production of savory flavors in the food industry. Its dipeptide structure contributes to the overall taste profile of various food products, making it a valuable addition to the flavor industry.
Used in Research and Development:
Glycyl-L-valine is used as a research tool in the field of biochemistry and molecular biology. Its unique properties make it an ideal candidate for studying peptide-protein interactions, enzyme activity, and other biological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 1963-21-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,9,6 and 3 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1963-21:
(6*1)+(5*9)+(4*6)+(3*3)+(2*2)+(1*1)=89
89 % 10 = 9
So 1963-21-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H14N2O3/c1-4(2)6(7(11)12)9-5(10)3-8/h4,6H,3,8H2,1-2H3,(H,9,10)(H,11,12)/t6-/m0/s1
1963-21-9Relevant articles and documents
-
Katakai,R. et al.
, p. 327 - 329 (1972)
-
Synthesis of dendritic oligo(aryl sulfone)s as supports for synthesis
Taylor, Paul C.,Wall, Michael D.,Woodward, Peter R.
, p. 12314 - 12322 (2007/10/03)
A short, divergent route to G1 oligo(aryl sulfone)s and a G 2 oligo(aryl sulfone) dendrimer using nucleophilic aromatic substitution reactions is described. A range of tetrasubstituted pentasulfones are proposed for applications as homogeneous supports for synthesis. Key to achieving selectivity in the syntheses is the activation of leaving groups by sulfide to sulfone oxidation. Preparation of the G2 oligo(aryl sulfone) is low-yielding due to competition from SET processes that are interesting from a mechanistic point of view. The utility of the supports is exemplified with a four step synthesis of a dipeptide and by 'react and release' synthesis of amides.
Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same
-
, (2008/06/13)
This invention particularly provides a novel polypeptide having high protease-inhibiting activity, preferably FXa-inhibiting activity, which comprises, at least as a part of the polypeptide, an amino acid sequence resulting from substitution of an amino acid for at least one amino acid in the following amino acid sequence (1), wherein the amino acid substitution is at least one substitution selected from the following substitution means (i) to (iii). It also provides a process for the production of the polypeptide, a novel DNA fragment encoding the polypeptide and a drug composition containing the same. Amino acid sequence (1) STR1 (i) Substitution of 15 position Gln counting from the N-terminus by an amino acid other than Gln. (ii) Substitution of 42 position Tyr counting from the N-terminus by an amino acid other than Tyr. (iii) Substitution of 7 position Arg counting from the N-terminus by an amino acid other than Arg.
